MktsMarkets

Boundless Bio, Inc.
NASDAQ: BOLDKey statistics
BOLD News
Stories mentioning BOLD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 9,734 | 9,816 | 10,673 | 12,218 | 12,138 | 13,314 | 14,089 | 14,735 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 14,475 | 14,002 | 15,148 | 17,061 | 17,341 | 18,278 | 18,715 | 19,391 |
| Operating Income (Loss) | (14,475) | (14,002) | (15,148) | (17,061) | (17,341) | (18,278) | (18,715) | (19,391) |
| Interest Income | 920.00 | 1,117 | 1,269 | 1,386 | 1,585 | 1,915 | 2,174 | 2,382 |
| Interest Expense | ||||||||
| Other Expense | 0.00 | 0.00 | 0.00 | (2.00) | (85.00) | 32.00 | 33.00 | |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (13,555) | (12,885) | (13,879) | (15,675) | (15,758) | (16,448) | (16,509) | (16,976) |
| Earnings Per Share (Basic) | (0.60) | (0.58) | (0.62) | (0.70) | (0.71) | (0.97) | (0.74) | (0.77) |
| Earnings Per Share (Diluted) | (0.60) | (0.58) | (0.62) | (0.70) | (0.71) | (0.97) | (0.74) | (0.77) |
| Weighted Average Shares Outstanding (Basic) | 22,407 | 22,360 | 22,386 | 22,356 | 22,300 | 16,984 | 22,254 | 22,023 |
| Weighted Average Shares Outstanding (Diluted) | 22,407 | 22,360 | 22,386 | 22,356 | 22,300 | 16,984 | 22,254 | 22,023 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BOLD
Boundless Bio, Inc. (NASDAQ: BOLD) is a stock listed on the Nasdaq Stock Market under the ticker symbol BOLD. It last traded at $2.50 (Nov 13, 2026, 4:00 PM ET), up 1.6% on the day. That gives Boundless Bio a market capitalisation of $59.0M.
Over the past 52 weeks BOLD has traded between $0.9600 and $3.16.
For the quarter ended Mar 31, 2026 it reported a net loss of $13.6M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$13.6M |
| Dec 31, 2025 | — | -$12.9M |
| Sep 30, 2025 | — | -$13.9M |
| Jun 30, 2025 | — | -$15.7M |
From Boundless Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…